INmune Bio (INMB) Stock Chart & Stock Price History → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free INMB Stock Alerts $10.19 +0.27 (+2.72%) (As of 12:37 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media INmune Bio Stock Price Performance5 Day Performance-5.39%1 Month Performance-1.92%3 Month Performance-27.21%6 Month Performance+48.76%Year-To-Date Performance-9.50%1 Year Performance+29.48% Receive INMB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressBiden to Drop BOMBSHELL June 13th?Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th!Click here now to see his shocking evidence. INMB Stock Chart for Tuesday, May, 14, 2024 INMB Chart by TradingView INmune Bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$10.02$9.92-1.00%$10.09$9.67154,436 shs$196.22 million05/10/2024$10.77$10.02-6.96%$10.67$9.90148,564 shs$182.36 million05/09/2024$10.48$10.77+2.77%$10.85$10.32107,133 shs$196.01 million05/08/2024$11.18$10.48-6.26%$11.09$10.34128,190 shs$190.74 million05/07/2024$11.20$11.18-0.18%$11.43$10.9463,843 shs$203.48 million05/06/2024$11.57$11.20-3.20%$11.76$11.11119,738 shs$203.84 million Get the Latest News and Ratings for INMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$11.13$11.57+3.95%$11.75$11.12124,724 shs$210.57 million05/02/2024$11.60$11.13-4.05%$11.99$10.81130,543 shs$202.57 million05/01/2024$11.84$11.60-2.03%$12.60$11.53242,826 shs$211.16 million04/30/2024$11.77$11.84+0.59%$12.72$11.32441,452 shs$215.49 million04/29/2024$11.29$11.77+4.25%$12.12$11.34257,998 shs$214.21 million04/26/2024$10.84$11.29+4.15%$11.73$10.8377,738 shs$205.48 million04/25/2024$10.62$10.84+2.07%$11.12$10.04115,735 shs$197.29 million04/24/2024$10.14$10.62+4.73%$10.73$9.88114,528 shs$193.28 million04/23/2024$10.63$10.14-4.56%$10.55$9.66178,611 shs$184.55 million04/22/2024$8.37$10.63+26.94%$10.73$8.40686,517 shs$193.38 million04/19/2024$8.80$8.37-4.89%$8.99$8.3069,216 shs$152.33 million04/18/2024$8.43$8.80+4.39%$8.89$8.4097,911 shs$158.66 million04/17/2024$9.15$8.43-7.87%$9.16$8.40148,236 shs$151.96 million04/16/2024$9.58$9.15-4.49%$9.64$8.80118,273 shs$164.97 million04/15/2024$10.39$9.58-7.80%$10.30$9.40125,932 shs$172.73 million04/12/2024$10.94$10.39-5.03%$11.01$10.2374,572 shs$187.29 million04/11/2024$10.84$10.94+0.92%$11.22$10.7054,199 shs$197.25 million04/10/2024$10.56$10.84+2.65%$11.30$10.47109,522 shs$195.45 million04/09/2024$10.36$10.56+1.93%$10.83$10.16176,411 shs$190.40 million04/08/2024$10.34$10.36+0.19%$10.77$10.14223,895 shs$186.79 million04/05/2024$10.25$10.34+0.88%$10.38$10.0276,402 shs$186.43 million04/04/2024$10.10$10.25+1.49%$10.59$9.84141,201 shs$184.81 million04/03/2024$10.95$10.10-7.76%$11.33$10.04176,498 shs$182.10 million04/02/2024$11.52$10.95-4.95%$11.58$10.62156,705 shs$197.32 million04/01/2024$11.75$11.52-1.96%$11.85$11.11110,261 shs$207.59 million03/29/2024$11.75$11.75$12.05$11.2896,495 shs$211.74 million03/28/2024$11.63$11.75+1.03%$12.05$11.2896,381 shs$211.74 million03/27/2024$11.88$11.63-2.10%$12.19$11.3792,870 shs$209.57 million03/26/2024$11.71$11.88+1.45%$12.00$11.5436,379 shs$214.08 million03/25/2024$12.20$11.71-4.02%$12.48$11.4463,723 shs$211.01 million03/22/2024$11.92$12.20+2.35%$12.38$11.5069,816 shs$219.84 million03/21/2024$11.59$11.92+2.85%$11.92$11.5042,684 shs$214.80 million03/20/2024$10.94$11.59+5.94%$11.64$10.9087,417 shs$208.85 million03/19/2024$11.02$10.94-0.73%$11.24$10.8074,234 shs$197.14 millionInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a Century (Ad)Starpax’s technology is set to revolutionize cancer care and improve the lives of patients worldwide. Be part of a mission to create a world where cancer treatment is more effective, safe and accessible.Invest today03/18/2024$11.06$11.02-0.36%$11.52$10.7980,772 shs$198.58 million03/15/2024$11.44$11.06-3.32%$11.83$11.0063,105 shs$199.30 million03/14/2024$11.81$11.44-3.13%$11.89$11.2557,447 shs$206.17 million03/13/2024$11.76$11.81+0.43%$12.09$11.6139,200 shs$212.84 million03/12/2024$11.72$11.76+0.34%$12.18$11.7030,937 shs$211.92 million03/11/2024$12.21$11.72-4.01%$12.28$11.6562,023 shs$211.19 million03/08/2024$12.50$12.21-2.32%$12.96$12.1059,937 shs$220.02 million03/07/2024$12.65$12.50-1.19%$13.25$12.32101,265 shs$225.25 million03/06/2024$12.17$12.65+3.94%$12.89$12.1832,748 shs$227.95 million03/05/2024$12.86$12.17-5.37%$13.03$12.0375,841 shs$219.30 million03/04/2024$12.39$12.86+3.79%$13.30$12.4978,999 shs$231.74 million03/01/2024$11.60$12.39+6.81%$12.55$11.6185,333 shs$223.27 million02/29/2024$11.82$11.60-1.86%$12.39$11.5943,742 shs$209.03 million02/28/2024$12.11$11.82-2.39%$12.30$11.16115,959 shs$213.00 million02/27/2024$13.11$12.11-7.63%$13.11$12.1197,046 shs$218.22 million02/26/2024$12.92$13.11+1.47%$13.52$12.90136,964 shs$236.24 million02/23/2024$12.67$12.92+2.01%$12.92$12.1140,807 shs$232.82 million02/22/2024$12.59$12.67+0.60%$13.09$12.2638,537 shs$228.22 million02/21/2024$13.50$12.59-6.74%$13.41$12.2379,334 shs$226.87 million02/20/2024$14.01$13.50-3.64%$14.41$13.0597,960 shs$243.27 million02/19/2024$14.01$14.01$14.49$13.52107,700 shs$252.46 million02/16/2024$13.78$14.01+1.67%$14.44$13.52107,715 shs$252.46 million02/15/2024$14.00$13.78-1.57%$14.40$13.61101,567 shs$248.34 million02/14/2024$12.17$14.00+15.04%$14.74$12.42248,202 shs$252.31 million02/13/2024$12.39$12.17-1.78%$12.54$11.8437,132 shs$219.30 million Related Companies: Acumen Pharmaceuticals Stock Chart Zura Bio Stock Chart Kodiak Sciences Stock Chart Opthea Stock Chart Innate Pharma Stock Chart Adverum Biotechnologies Stock Chart Compugen Stock Chart Elevation Oncology Stock Chart Century Therapeutics Stock Chart X4 Pharmaceuticals Stock Chart Receive INMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INMB) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INmune Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.